For the year ending 2025-12-31, MBRX has $22,126K in assets. $7,120K in debts. $8,878K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 8,878 | |||
| Prepaid expenses and other current assets | 808 | |||
| Total current assets | 9,686 | |||
| Furniture and equipment, net | 78 | |||
| Intangible assets | 11,148 | |||
| Other non-current assets | 900 | |||
| Operating lease right-of-use asset | 314 | |||
| Total assets | 22,126 | |||
| Accounts payable | 3,508 | |||
| Accrued expenses and other current liabilities | 3,346 | |||
| Total current liabilities | 6,854 | |||
| Operating lease liability - long-term, net of current portion | 222 | |||
| Warrant liability | 44 | |||
| Total liabilities | 7,120 | |||
| Common stock, 0.001 par value 500,000,000 and 100,000,000 authorized shares as of december 31, 2025 and december 31, 2024, respectively, 3,199,228 and 135,155 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 3 | |||
| Additional paid-in capital | 220,997 | |||
| Accumulated other comprehensive income (loss) | 10 | |||
| Accumulated deficit | -206,004 | |||
| Total stockholders' equity | 15,006 | |||
| Total liabilities and stockholders' equity | 22,126 | |||
Moleculin Biotech, Inc. (MBRX)
Moleculin Biotech, Inc. (MBRX)